0001179110-12-012003.txt : 20120730 0001179110-12-012003.hdr.sgml : 20120730 20120730214854 ACCESSION NUMBER: 0001179110-12-012003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120726 FILED AS OF DATE: 20120730 DATE AS OF CHANGE: 20120730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Woo Deborah CENTRAL INDEX KEY: 0001441748 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 12995080 MAIL ADDRESS: STREET 1: 3838 W PARKWAY BLVD CITY: SALT LAKE CITY STATE: X1 ZIP: 84120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 4 1 edgar.xml FORM 4 - X0306 4 2012-07-26 0 0000896264 USANA HEALTH SCIENCES INC USNA 0001441748 Woo Deborah 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120 0 1 0 0 President of Asia Pacific Common Stock 2012-07-26 4 M 0 201 40.59 A 201 D Common Stock 2012-07-26 4 S 0 201 43.04 D 0 D Common Stock 2012-07-26 4 M 0 3795 26.06 A 3795 D Common Stock 2012-07-26 4 S 0 3795 43.04 D 0 D Common Stock 2012-07-27 4 M 0 3679 26.06 A 3679 D Common Stock 2012-07-27 4 S 0 1575 44.45 D 2104 D Common Stock 2012-07-27 4 S 0 2104 45.00 D 0 D Stock-Settled Stock Appreciation Rights 40.59 2012-07-26 4 M 0 6000 0 D 2008-04-19 2012-10-19 Common Stock 6000 0 D Stock-Settled Stock Appreciation Rights 26.06 2012-07-26 4 M 0 10000 0 D 2009-07-21 2014-01-21 Common Stock 10000 38000 D Stock-Settled Stock Appreciation Rights 26.06 2012-07-27 4 M 0 9000 0 D 2009-07-21 2014-01-21 Common Stock 9000 29000 D The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II. Deborah Woo 2012-07-30